These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30746239)

  • 1. Evaluation of lobar lymph node metastasis in non-small cell lung carcinoma using modified total lesion glycolysis.
    Dejima H; Kuroda H; Oya Y; Sakakura N; Inaba Y; Tamaki T; Yatabe Y; Sakao Y
    J Thorac Dis; 2018 Dec; 10(12):6932-6941. PubMed ID: 30746239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic utility of metabolic parameters on FDG PET/CT for lymph node metastasis in patients with cN2 non-small cell lung cancer.
    Nakanishi K; Nakamura S; Sugiyama T; Kadomatsu Y; Ueno H; Goto M; Ozeki N; Fukui T; Iwano S; Chen-Yoshikawa TF
    BMC Cancer; 2021 Sep; 21(1):983. PubMed ID: 34474680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic value of metabolic, morphological and heterogeneous parameters of 18F-FDG PET/CT in mediastinal lymph node metastasis of non-small cell lung cancer.
    Hua J; Li L; Liu L; Liu Q; Liu Y; Chen X
    Nucl Med Commun; 2021 Nov; 42(11):1247-1253. PubMed ID: 34269750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value on SUV-derived parameters assessed on
    Liao X; Liu M; Li S; Huang W; Guo C; Liu J; Xiong Y; Zhang J; Fan Y; Wang R
    BMC Med Imaging; 2023 Apr; 23(1):49. PubMed ID: 37020286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of 18-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in the differential diagnosis of sarcoidosis and lung cancer with lymph node metastasis: a retrospective study.
    Chen X; Xu X; Chrysikos S; Zhao M; Zhou Y
    Transl Lung Cancer Res; 2022 Sep; 11(9):1926-1935. PubMed ID: 36248335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of occult lymph node metastasis using volume-based PET parameters in small-sized peripheral non-small cell lung cancer.
    Park SY; Yoon JK; Park KJ; Lee SJ
    Cancer Imaging; 2015 Dec; 15():21. PubMed ID: 26694918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings.
    Konishi J; Yamazaki K; Tsukamoto E; Tamaki N; Onodera Y; Otake T; Morikawa T; Kinoshita I; Dosaka-Akita H; Nishimura M
    Respiration; 2003; 70(5):500-6. PubMed ID: 14665776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Investigation of the Relationship Between
    Kandemir O; Demir F
    Curr Radiopharm; 2024; 17(1):111-116. PubMed ID: 37644744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combinative evaluation of primary tumor and lymph nodes in predicting pelvic lymphatic metastasis in early-stage cervical cancer: A multiparametric PET-CT study.
    Li K; Sun H; Guo Q
    Eur J Radiol; 2019 Apr; 113():153-157. PubMed ID: 30927941
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Sun Y; Sun Y; Li Z; Song S; Wu K; Mao J; Cheng J
    Eur J Med Res; 2024 Jan; 29(1):9. PubMed ID: 38173034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-to-liver standard uptake ratio using fluorine-18 fluorodeoxyglucose positron emission tomography computed tomography effectively predict occult lymph node metastasis of non-small cell lung cancer patients.
    Shi YM; Niu R; Shao XL; Zhang FF; Shao XN; Wang JF; Wang XS; Liu B; Yu WJ; Wang YT
    Nucl Med Commun; 2020 May; 41(5):459-468. PubMed ID: 32187163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significance of dual-time-point 18F-FDG PET imaging in evaluation of hilar and mediastinal lymph node metastasis in non-small-cell lung cancer].
    Hu M; Yu JM; Liu NB; Liu LP; Guo HB; Yang GR; Zhang PL; Xu XQ
    Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):306-9. PubMed ID: 18788639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of F-18 FDG PET/CT with optimal cut-offs of maximum standardized uptake value according to size for diagnosis of regional lymph node metastasis in patients with rectal cancer.
    Bae SU; Won KS; Song BI; Jeong WK; Baek SK; Kim HW
    Cancer Imaging; 2018 Sep; 18(1):32. PubMed ID: 30217167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic Tumor Volume on 18F-FDG PET/CT Improves Preoperative Identification of High-Risk Endometrial Carcinoma Patients.
    Husby JA; Reitan BC; Biermann M; Trovik J; Bjørge L; Magnussen IJ; Salvesen ØO; Salvesen HB; Haldorsen IS
    J Nucl Med; 2015 Aug; 56(8):1191-8. PubMed ID: 26045311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semiquantitative assessment of fluorodeoxyglucose uptake in primary tumours on dynamic PET/computed tomography for lymph node metastasis evaluation in patients with lung cancer: a prospective study.
    Yamanaka M; Shinya T; Otomi Y; Kubo M; Arai Y; Toba H; Bando Y; Otsuka H; Harada M
    Nucl Med Commun; 2020 Nov; 41(11):1189-1198. PubMed ID: 32796454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New PET/CT criterion for predicting lymph node metastasis in resectable advanced (stage IB-III) lung cancer: The standard uptake values ratio of ipsilateral/contralateral hilar nodes.
    Kameyama K; Imai K; Ishiyama K; Takashima S; Kuriyama S; Atari M; Ishii Y; Kobayashi A; Takahashi S; Kobayashi M; Harata Y; Sato Y; Motoyama S; Hashimoto M; Nomura K; Minamiya Y
    Thorac Cancer; 2022 Mar; 13(5):708-715. PubMed ID: 35048499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic FDG-PET imaging for differentiating metastatic from non-metastatic lymph nodes of lung cancer.
    Wumener X; Zhang Y; Wang Z; Zhang M; Zang Z; Huang B; Liu M; Huang S; Huang Y; Wang P; Liang Y; Sun T
    Front Oncol; 2022; 12():1005924. PubMed ID: 36439506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving diagnostic performance of
    Yang DD; Mirvis E; Goldring J; Patel ARC; Wagner T
    Clin Radiol; 2019 Oct; 74(10):818.e17-818.e23. PubMed ID: 31420186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal FDG PET/CT volumetric parameters for risk stratification in patients with locally advanced non-small cell lung cancer: results from the ACRIN 6668/RTOG 0235 trial.
    Salavati A; Duan F; Snyder BS; Wei B; Houshmand S; Khiewvan B; Opanowski A; Simone CB; Siegel BA; Machtay M; Alavi A
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1969-1983. PubMed ID: 28689281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of false negative and false positive diagnosis in lymph node staging of NSCLC by means of ¹⁸F-FDG PET/CT.
    Li S; Zheng Q; Ma Y; Wang Y; Feng Y; Zhao B; Yang Y
    PLoS One; 2013; 8(10):e78552. PubMed ID: 24205256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.